Milton To

Title: Milton To - Innovator in Antigen-Binding Molecules

Introduction

Milton To is a notable inventor based in San Lorenzo, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antigen-binding molecules. His work focuses on innovative methods for targeting specific proteins associated with cancer treatment.

Latest Patents

Milton To holds a patent for "Compositions targeting prostate-specific membrane antigen and methods for making and using the same." This patent describes antigen-binding molecules that exhibit binding specificity to the cluster of differentiation T cell receptor (CD) and prostate-specific membrane antigen (PSMA). The disclosure also includes cleavable linker sequences and protease-activatable bispecific fusion proteins, such as protease-activatable T cell engagers, along with their uses and methods of treatment. He has 1 patent to his name.

Career Highlights

Milton To is currently employed at Amunix Pharmaceuticals, Inc., where he continues to advance his research in the field of immunotherapy. His work is pivotal in developing new therapeutic strategies for cancer treatment.

Collaborations

Milton collaborates with talented professionals in his field, including Viktoriya Dubrovskaya and Eric Johansen. Their combined expertise contributes to the innovative projects at Amunix Pharmaceuticals.

Conclusion

Milton To is a distinguished inventor whose work in antigen-binding molecules is paving the way for advancements in cancer treatment. His contributions are vital to the ongoing research and development in biotechnology.